Immunotherapy in Gastrointestinal Carcinoma - How to Separate Hope from Hype.

Moehler, Markus

Moehler, Markus.

Oncol Res Treat ; 41(5): 264-265, 2018.

Article in En | MEDLINE | ID: mdl-29705785

Subject(s)

Antineoplastic Agents, Immunological/therapeutic use; Carcinoma/therapy; Gastrointestinal Neoplasms/therapy; Immunotherapy/methods; Patient Selection; Antineoplastic Agents, Immunological/pharmacology; Biomarkers, Tumor/analysis; Biomarkers, Tumor/antagonists & inhibitors; Biomarkers, Tumor/immunology; Carcinoma/immunology; Carcinoma/pathology; Costimulatory and Inhibitory T-Cell Receptors/analysis; Costimulatory and Inhibitory T-Cell Receptors/antagonists & inhibitors; Costimulatory and Inhibitory T-Cell Receptors/immunology; Gastrointestinal Neoplasms/immunology; Gastrointestinal Neoplasms/pathology; Hope; Humans; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma / Patient Selection / Antineoplastic Agents, Immunological / Gastrointestinal Neoplasms / Immunotherapy Limits: Humans Language: En Journal: Oncol Res Treat Year: 2018 Document type: Article Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google